Skip to main content

Table 2 Lipid profile according to LRP8 R952Q in non-diabetic subjects without lipid-lowering therapy (n = 449)

From: Additive effect of LRP8/APOER2 R952Q variant to APOE ε2/ε3/ε4 genotype in modulating apolipoprotein E concentration and the risk of myocardial infarction: a case-control study

LRP8 R952Q variant

RR

(n = 190)

RQ

(n = 193)

QQ

(n = 66)

P*

Total cholesterol (mmol/l)

5.63 ± 1.10

5.90 ± 1.15

5.68 ± 0.90

0.774

LDL-cholesterol (mmol/l)

3.75 ± 0.98

3.92 ± 1.02

3.84 ± 0.80

0.546

HDL-cholesterol (mmol/l)

1.30 ± 0.37

1.36 ± 0.39

1.27 ± 0.37

0.643

Triglyceride (mmol/l)

1.63 ± 0.83

1.74 ± 0.86

1.70 ± 0.92

0.530

Apo A-I (g/l)

1.34 ± 0.25

1.36 ± 0.26

1.31 ± 0.25

0.426

Apo B (g/l)

1.13 ± 0.29

1.18 ± 0.27

1.17 ± 0.32

0.129

Apo C-III (mg/dl)

10.9 ± 3.2

11.5 ± 3.8

11.1 ± 3.7

0.825

ApoE (g/l)

0.045 ± 0.020

0.044 ± 0.014

0.040 ± 0.008

0.047

  1. *: by ANOVA with polynomial contrasts for linear trend